Patents by Inventor Anton Novak

Anton Novak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7105161
    Abstract: A modulated immune response to an antigen is achieved by coadministering the antigen and a genetically-detoxified pertussis holotoxin, particularly one retaining its immunogenicity, to a host. The modulated immune response enables immunogenic compositions, including multivalent pediatric vaccines such as DTP, to be provided which produce a modulated immune response in the absence of extrinsic adjuvants such as alum. The adjuvanting effect achieved by the genetically-detoxified pertussis holotoxin enables at least the same level of adjuvanting effect to be achieved as previously attained by alum, without the undesirable side effects thereof.
    Type: Grant
    Filed: June 8, 1995
    Date of Patent: September 12, 2006
    Assignee: Sanofi Pasteur Inc.
    Inventors: Diane M. Gajewczyk, Heather A. Boux, Anton Novak, Michel H. Klein
  • Publication number: 20030072774
    Abstract: A modulated immune response to an antigen is achieved by coadministering the antigen and a genetically-detoxified pertussis holotoxin, particularly one retaining its immunogenicity, to a host. The modulated immune response enables immunogenic compositions, including multivalent pediatric vaccines, such as DTP, to be provided which produce a modulated immune response in the absence of extrinsic adjuvants, such as alum. The adjuvanting effect achieved by the genetically-detoxified pertussis holotoxin enables at least the same level of adjuvanting effect to be achieved as previously attained by alum, without the undesirable side effects thereof.
    Type: Application
    Filed: June 7, 1995
    Publication date: April 17, 2003
    Inventors: DIANE M. GAJEWCZYK, HEATHER A. BOUX, ANTON NOVAK, MICHEL H. KLEIN